摘要
目的:阐明cm yc 表达在肾癌发生、发展中的作用及临床意义。方法:利用免疫组织化学 A B C 法结合微波抗原修复和流式细胞技术,对cm yc 蛋白在 52 例肾癌组织及 14 例癌旁正常肾组织中的表达进行了定性、定量的测定。结果:肾癌组织中cm yc 蛋白的阳性率和阳性细胞率分别为76.92% 和65.45% ±29.19% ,高于正常肾组织的14.29% 和8.59% ±3.66% ( P < 0.005)。cm yc在肾癌组织中55.77% 分布于胞浆,21.15% 分布于胞核,而在正常肾组织则全部分布于胞核。其胞浆表达在病理 G2、 G3 级高于 G1 级(χ2= 9.244, P < 0.005);临床分期 T3、 T4 期高于 T1、 T2 期( P< 0.001)。结论:cm yc 的胞浆表达促进肾癌的发生、发展,并与恶性程度、临床分期有关,是预后不良的重要指征。
Purpose:To get to know the effect of c myc protein on the onset and development of renal cell carcinoma and clinical progress.Methods:We have detected expression of c myc protein qualitatively and quantitatively in 14 cases normal tissue and 52 cases renal cell carcinoma(RCC). Using immunohistochemical technique,and cytoflowmetry and cytoimmunofluorescence.Results:Normal tissue showed staining only of some nuclei while in RCC staining varied from predominantly nuclear to focal or pancytoplasma. Positive rate and positive cell rate of c myc protein were 76.92 % and 65.45 %± 29.19 % respectively in RCC,they were significant higher than those ( 14.29 % and 8.59 %± 3.66 %) of the normal tissue (P< 0.005 ). Cytoplasmic expression of c myc was related to high pathological grade (χ 2= 9.244 ,P< 0.005 ) and high clinical stage (P< 0.001 ).Conclusions:Cytoplasmic expression of c myc might play important roles in the pathogenisis and was helpful in the evaluation of prognose of patients in RCC.
出处
《临床泌尿外科杂志》
1999年第9期403-405,共3页
Journal of Clinical Urology